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WHAT'S ALREADY KNOWN ABOUT THIS TOPIC? 
Numerous studies of postnatal cohorts show that consanguineous couples have an increased 
risk of major anomalies in their offspring. Up to now, no comprehensive study exists showing 
that the risk of major congenital anomalies in the offspring of consanguineous couples is 
higher than previously estimated if the prenatal situation is included 
 
WHAT DOES THIS STUDY ADD? 
Adjusted frequencies of major anomalies were 2.8% in non-consanguineous,6.1% in 
consanguineous couples (8.5% in first cousin progeny, 3.9% in beyond first cousin). 
Applying a further adjustment for the significantly different frequencies of trisomic 
pregnancies (consanguineous: n = 1, non-consanguineous: n = 262), the overall risks were 
2.0% and 5.9% respectively, i.e. a 3.9% excess risk attributable to consanguinity, 6.1% at 
first cousin level , 1.9% beyond first cousin level. 
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Statement: Ethics 
The data are anonymized retrospective evaluations of normal clinical treatment.  Institutional 
or national ethical committee approval is therefore not required. 
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OBJECTIVE: Aim of the present study was to assess the risk of  major anomalies in the 
offspring of consanguineous couples, including data of the prenatal situation. 
METHODS: Over 20 years (1993-2012), 35,391 fetuses were examined by prenatal 
sonography. In 675 cases (1.9%) parents were consanguineous, with 307 couples (45.5%) 
related as first cousins, 368 couples (54.5%) beyond first cousins,. Detailed information was 
retrieved on 31,710 (89.6%) fetuses, (consanguineous 568: 1.8%). 
RESULTS: Overall prevalence of major anomalies among fetuses with non-consanguineous 
parents was 2.9% (consanguineous: 10.9%: first cousins 12.4%, beyond first cousins 6.5%). 
Adjusting the overall numbers for cases having been referred because of a previous index 
case, the prevalences were 2.8% (non-consanguineous) and 6.1% (consanguineous) (first 
cousin 8.5%, beyond first cousin 3.9%). Further adjustment for differential rates of trisomic 
pregnancies indicated 2.0%/5.9% congenital anomalies (non-consanguineous/consanguineous 
groups), i.e. a consanguinity-associated excess of 3.9%, 6.1% in first cousin progeny and 
1.9% beyond first cousin. 
CONCLUSIONS: The prevalence of major fetal anomalies associated with consanguinity is 
higher than in evaluations based only on postnatal life. It is important that this information is 
made available in genetic counselling programmes, especially in multi-ethnic and multi-
religious communities, to enable couples to make informed decisions. 
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Introduction 
Marriages between couples related as second cousins or closer are common in many societies 
and it is estimated that at least 10.4% of the current world population of 7.2 billion people are 
consanguineous, with first cousin marriages by far the most prevalent type of intra-familial 
union.1-3 The frequency of consanguineous marriage is especially high in South, Central and 
West Asia, and in North and sub-Saharan Africa2, and in countries such as Pakistan first 
cousin marriages alone account for >50% of all marital unions.4 Given the presence of large 
Asian and African immigrant communities in Europe, North America, and Oceania5-14
Data from epidemiological studies evaluating health outcomes have consistently shown that 
the offspring of consanguineous parents may be at increased risk of morbidity and death in 
the first years of life, due to the expression of detrimental recessive genes co-inherited from a 
common ancestor.
, 
consanguineous pregnancies are now routinely encountered in many antenatal clinics in 
Western countries, which has resulted in heightened interest in the possible association 
between consanguinity and adverse pregnancy outcomes. 
1,3,15-19 A recent multi-population meta-analysis indicated a mean excess 
infant death rate of 1.3% in the progeny of first cousins, with a total excess pre-reproductive 
mortality at first cousin level of 3.7%.2 When compared with non-consanguineous offspring, 
first cousin progeny had a 4.4% mean excess risk of a major congenital defect (median excess 
risk = 3.3%).
To date, information on the effects of consanguinity on fetal well-being have been very 
limited, with few representative data available on fetal losses or on the prevalence of major 
congenital anomalies. Since a proportion of pregnancies with major anomalies may end in 
intrauterine death, or in medical termination, estimates of fetal defects based only on 
postnatal data may be misleading. The present detailed study was therefore undertaken to 
provide information on two important topics: 
 2 
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1) The frequency of fetuses with consanguineous parentage in a major European metropolitan 
population; 
2) The comparative frequency of major anomalies resulting in intrauterine or neonatal death 
(IUD/NND), medical termination of pregnancy (MTOP), and neonatal survival in the 
offspring of consanguineous and non-consanguineous parents. 
 
Patients and Methods 
The study was based on sonographic examinations (some undertaken in combination with 
sonographically guided invasive procedures) conducted in a specialist reference centre in 
Berlin, the capital of Germany over a 20-year period (January 2, 1993 to December 30, 
2012). A total of 35,391 fetuses in 34,256 pregnancies with a gestational age of more than 10 
weeks underwent prenatal examination, including 953 sets of twins, 73 sets of triplets and 12 
sets of quadruplets. 
Various reasons for referral were given, including a positive family history; suspicion of a 
malformation raised by a referring colleague; problems in sonographic depiction, for 
example, because of maternal obesity; or concern of the pregnant woman with regard to 
possible fetal anomalies and her wish, and that of the referring physician, to exclude fetal 
anomalies wherever possible. However, in the latter instance the German legal guidelines on 
pregnancy surveillance curtail the right of a woman to be referred for a detailed scan only 
where there is suspicion of an anomaly. 
All ultrasound examinations were performed by a single operator (RB), and the sonographic 
instruments used were, respectively, an Acuson 128XP10, a Siemens Acuson Sequoia, and a 
GE Voluson E8. In addition to the ultrasound examinations, patients’ histories were assessed 
by questionnaires as well as personal interviews. 
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The ultrasound examinations were conducted between 10+0 and 42+0 weeks gestation 
(median 21+2 weeks), with 11,108 fetuses examined between 10+0 and 13+6 weeks, i.e. at 
the first trimester anomaly scan, and 16,814 fetuses examined between 20+0 and 23+6 
weeks, i.e. at the second trimester anomaly scan. A total of 4,771 fetuses were examined 
between 14+0 and 19+6 weeks and 2,698 fetuses between 24+0 and 41+3 weeks. According 
to the German system of perinatal care, all newborns were examined by a midwife 
immediately after birth and by a paediatrician between days five and ten of life. Reports on 
the health status of the newborns, either provided by mothers or in medical reports, were 
based on the results of these mandatory examinations. A major anomaly was defined as a 
defect present during pregnancy after 10 weeks gestation that, in the absence of treatment, 
either was incompatible with life or would lead to a severe handicap and would be detectable 
during the paediatric examination at five to 10 postnatal days.
As part of a standardized form distributed during the explanatory talk preceding ultrasound 
examination, each patient was asked during the first prenatal interview whether she and her 
partner were biological relatives, and if so the nature of their relationship, i.e. categorized as 
first cousin, equivalent to a coefficient of inbreeding, F = 0.0625, or related to a lesser 
degree, F<0.0625. All patients also were requested to complete and return a feedback form 
after delivery, containing information on their pregnancy, the birth, and the health of their 
newborn. 
20,21 
Feedback on the fetal outcome was retrieved for 31,710 (89.6%) of the 35,391 cases, 
representing 568/675 (84.1%) of the consanguineous and 31,141/34,716 (89.7%) of the non-
consanguineous cases respectively (Table 2). In 15,730 cases (consanguineous, n = 191) the 
form was returned by the patient, and in 15,411 cases (consanguineous, n = 377) by 
contacting the patient or, especially in cases with an adverse pregnancy outcome, via the 
referring physician or the hospital where the child had been delivered or the pregnancy had 
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been terminated. The information on the health status of the fetus/newborn contained all 
ultrasound results during the pregnancy as well as post-partum information retrieved by the 
second routine examination of the newborn performed between day 5 and 10 of neonatal life. 
A majority of the ultrasound examinations was undertaken for screening purposes.  
In patients with a congenital anomaly, the frequency referred because of the medical history 
of an index child with an autosomal recessive disorder in the consanguineous group was 
much higher (29 of 62: 46,8%) than in the non-consanguineous group (10 of 893: 1.1%) 
(Table 3, Suppl. Table 5).. 
Data on ethnicity and maternal age were available for all 675 consanguineous cases and for 
34,526 (99.5%) of the non-consanguineous fetuses (Table 1). Patients were classified into 
five major groups: 
1. European, predominantly German, but also parents from other European countries and of 
European ancestry, including North and South America, Russia and Australia; 
2. Turkish, i.e. parents from Turkey, which may include parents of Kurdish ethnicity; 
3. Eastern Mediterranean, i.e. from Iran, Iraq, Israel, Kuwait, Lebanon, Oman, Palestine, 
Syria, Saudi Arabia, and Yemen; also Egypt and the Maghreb states Algeria, Libya, 
Morocco, Tunisia, as well as Pakistan and Sudan; 
4. African, mainly sub-Saharan, and  
5. South, Southeast and East Asian, i.e. Bangladesh, China, India, Indonesia, Nepal, The 
Philippines. 
The data on an association between consanguinity and a major fetal anomaly were divided 
into three categories  A causative association between consanguinity and fetal or neonatal 
disease was assessed as: 
1. Probable: if i) the disease was rare and had a well described autosomal recessive mode of 
inheritance, and/or, ii) there were several identical anomalies affecting fetuses previously 
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conceived by a woman (or in the pregnancies of close biological relatives), with a suspected 
but as yet unproven autosomal recessive mode of inheritance; 
2. Possible: in cases of anomalies that may occur as autosomal recessive diseases but where 
the mode of inheritance was unclear and no repeat case was known; 
3. Improbable: in cases known not to have an autosomal recessive mode of inheritance, and 
in cases with numerical or structural chromosomal abnormalities. 
The statistical analysis was performed using the SAS®9.2 program (SAS Institute Inc., Cary, 
North Carolina, USA). Summary statistics are presented as counts and percentages in the case 
of categorically scaled measures and as mean, median, standard deviation and range in the 
case of continuously scaled variables, with the fetus or the mother as the unit of analysis. 
Multivariable Poisson regression was undertaken to investigate the effect of consanguinity on 
the occurrence of anomalies, with the analysis adjusted for maternal age, ethnicity and the 
birth number (1
Statistical analysis 
st pregnancy: y/n). The latter adjustment was performed in order to address a 
possible referral bias. Pregnancy was the unit within these analyses; in the case of multiple 
pregnancies the fetus with worst birth outcome was used in the analysis. As a further 
sensitivity analysis to address missing information on fetal outcome, the Poisson regression 
was repeated by applying multiple imputation22 of missing information (SAS procedures 
PROC MI, PROC MIANALYZE, 20 imputation cycles), under the assumption that missing 
outcome information (MAR) could be explained by consanguinity, ethnicity, maternal age 
and first pregnancy y/n ("missing at random assumption" (MAR)23)
 
. 
Results 
Of the total 35,391 fetuses examined 676 (1.9%) were the offspring of consanguineous 
parents. In one of these cases the pregnancy was conceived by egg donation and so it was 
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categorized as genetically non-consanguineous, resulting in 675 fetuses conceived by 
consanguineous parents (Table 1). Within this group, the parents of 307/675 (45.5%) fetuses 
were first cousins, with an established outcome in 275 cases; the parents of 368/675 (54.5%) 
fetuses were related beyond first cousin, with an established outcome in 293 cases. 
The frequency of parental consanguinity varied significantly according to the ethnicity of the 
mothers, from just 0.07% in European, predominantly German couples, to 21.8% 
consanguinity in couples of Eastern Mediterranean/Maghreb ethnicity who formed 33.6% of 
the total consanguinity group, and 17.2% in women of Turkish origin who comprised 61.5% 
of all consanguineous cases (Table 1). 
The overall frequency of major anomalies was 893/31,141 (2.9%) in the non-consanguineous 
group, 22 of them with a well known autosomal-recessive background (Table 3, Suppl. Table 
5). In the consanguineous group, the frequency of major anomalies was 62/568 (10.9%). As 
previously noted, in the consanguineous group 29/62 cases had been referred because of a 
preceding index case, by comparison with 10/893 non-consanguineous cases (Suppl. Table 
5). Adjusting for the pregnancies with preceding index cases and analysing in terms of the 
level of parental consanguinity the percentages of congenital anomalies diagnosed were: all 
consanguineous 6.1% (33 of 539), first cousin 8.5% (22 of 259), beyond first cousin 3.9% (11 
of 280), and non-consanguineous 2.8% (883 of 31,131) (Tables 2, 3). 
The frequency of anatomically complex diseases also was higher in the total consanguineous 
(3.7%) than in the non-consanguineous (1.5%) group. Conversely, while 0.7% of the 
consanguineous group was diagnosed with chromosomal anomalies with 177 cases of 
trisomy 21, 56 cases of trisomy 18 and 29 cases of trisomy 13., the prevalence of 
chromosomal anomalies in the non-consanguineous group was 1.2% (Table 2) with 1 case of 
trisomy 21 and no cases of trisomy 13 or 18.  
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Additional investigative procedures, including chorionic villous sampling, amniocentesis and 
fetal blood sampling, were less frequently undertaken in the pregnancies of women in a 
consanguineous relationship (7.0%) than non-consanguineous women (11.7%). A similar 
pattern emerged in the cases where a major anomaly was suspected, with 14.5% of 
consanguineous cases as opposed to 30.7% of non-consanguineous pregnancies further 
investigated (Suppl. Table 1). 
Detailed information on the 62 cases of major anomalies considered to be probably, possibly, 
or improbably associated with parental consanguinity is presented in Tables 3 and 4. In cases 
1-37 (59.7%), 21 of whom had first cousin parents and 16 with parents related beyond first 
cousins, a causal relationship of the disease with consanguinity was assessed as probable, e.g. 
glycogenosis or SMA Werdnig-Hoffmann (Table 3). In cases 38-56 (30.6%), 11 of whom 
had first cousin parents and 8 with parents related beyond first cousins, an association 
between the major anomaly and consanguinity was possible but could not be proven, e.g. 
hydrops of unknown aetiology (Table 4). In cases 57-62 (9.7%), all of whose parents were 
first cousins, there was no obvious association between the major anomaly and parental 
consanguinity, e.g. Klinefelter syndrome (Table 4). In 10/37 cases listed in Table 3 a 
diagnosis was possible by molecular diagnostics following an invasive procedure; in 3 further 
cases of this group diagnosis would have been possible but was declined by the pregnant 
woman. 
Intra-uterine death occurred in 9.7% of the consanguineous fetuses versus 4.9% of the non-
consanguineous pregnancies, and the corresponding data on medical terminations of 
pregnancy were 50.0% and 60.9% respectively. Nine of 62 (14.5%) fetuses of 
consanguineous progeny with major anomalies died within the first year of life, 3 within the 
first week. Detailed information on the time and mode of detection as well as time and mode 
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of the demise (unless the newborn survived) of the fetus/newborn are given in columns 6 and 
9 of table 3 and columns 5 and 8 of table 4. 
The results of adjusted, multivariable analyses (without and with multiple imputation of 
missing information) are presented as Supplementary Results. A ratio of abnormalities 
Cons/P/NConsP of 3.00 (95% CI: 2.17 – 4.14) [multiple imputation: 3.00 (95% CI= 2.15 – 
4.19)] was found. In the preparation of multiple imputation, all investigated variables were 
identified as explanatory variables for missing information of outcome (Suppl. Table 1).  
 
Discussion 
To the best of our knowledge this is the first comprehensive study analysing the impact of 
consanguinity on the frequency of congenital anomalies which includes comprehensive data 
on prenatal life from week 10 onwards. Besides the integration of prenatal data, a major 
advantage of the evaluation is the size of the study group which gives a representative picture 
of the diagnostic situation faced.  
The overall frequency of fetuses with consanguineous parentage in our study population was 
low (1.9%) in comparison to the many countries where 20-50+% of all marriages are 
consanguineous (www.consang.net).2,3
The investigation was based on retrospective data gained as part of the daily routine of a 
specialist prenatal practice over 20 years. When such observational data are analysed possible 
biases influencing the result have to be considered. First, one could assume that the women 
undergoing prenatal diagnosis following their first pregnancy might differ from those women 
who visited the practice during their first pregnancy (1
 Consanguinity was strongly associated with ethnicity: 
consanguineous relationships were most common among couples of Turkish or Eastern 
Mediterranean/Maghreb origin, with 95.1% of all consanguineous fetuses studied conceived 
by couples from these backgrounds. 
st pregnancy y/n). We therefore 
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undertook a multivariable analysis investigating the effect of consanguinity on the occurrence 
of anomalies and adjusted the analysis for this factor (together with age and ethnicity). The 
related IDR (1st pregnancy y/n) was 1.03 (95%-CI: 0.90 - 1.19, p = 0.62), indicating that such 
bias was negligible (Suppl. Table 1). Second, the feedback rate of pregnancies was lower in 
the consanguineous (84.1%) than in the non-consanguineous (89.6%) group, which might 
also influence the result. We therefore used multiple imputation22, assuming that the rate of 
missing information on the occurrence of an anomaly can completely be explained by 
variables (consanguinity, age, ethnicity, first pregnancy (y/n)) investigated in the study (MAR 
assumption).23
The analysis thus shows that with respect to these possible variables the original analysis of 
10.9% vs. 2.9% (ratio 3.8) congenital anomalies in the consanguineous and non-
consanguineous groups moderately overestimated the apparent influence of consanguinity on 
the occurrence of anomalies, i.e. consanguinity significantly influences the occurrence of 
anomalies independently of other factors. It therefore is appropriate to present further detailed 
analyses simply as counts and percentages. 
 Although all variables could potentially influence the rate of missing 
information, the overall result was almost identical: (MI analysis: IDR (cons y/n) = 3.00 
(95%-CI: 2.15 - 4.19, p<0.0001) vs. complete case analysis: 3.00 (95%CI: 2.17 - 4.14, p = 
0.0001) (Suppl. Table 1). 
In overall terms, Table 3 lists 8 cases with a congenital anomaly probably associated with 
consanguinity because of an established autosomal recessive inheritance but without a 
preceding index child. Table 4 lists 19 cases possibly related to consanguinity and 6 cases 
probably not related to consanguinity. 
The degree of consanguinity had important influence on the frequency of major anomalies: 
looking at all consanguineous cases, the frequency of 6.1% could be differentiated into a 
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subgroup of first cousin relations with a frequency of major anomalies of 8.5% and a 
subgroup beyond first cousin with  a frequency of 3.9% respectively. 
Having adjusted for previously diagnosed index cases and assuming similar background risks 
in the consanguineous and non-consanguineous cases, congenital anomaly rates of 33/539 
(6.1%) and 883/31,131 (2.8%) are indicated in the cases with consanguineous and non-
consanguineous parentage respectively. 
Consanguineous women were, however, significantly younger than non-consanguineous 
women (Table 1) resulting in a differential age-dependent frequency of trisomies. In the non-
consanguineous group there were 262 trisomy cases (T21: n = 177; T18: n = 56; T13: n = 
29), i.e. a frequency of 262/893 (29.3%) major anomalies. As previously noted, this group of 
non-consanguineous fetuses also comprised 22 cases with an established autosomal recessive 
mode of inheritance (Suppl. Table 5), 10 of whom had a preceding index case. 
The background frequency of the non-consanguineous group corrected for autosomal 
recessive cases with a preceding index case and trisomies results in an adjusted frequency of 
[(893-10-262)/(31,141-10-262)] = 2.0%. By comparison, in the consanguineous group, 
besides the autosomal recessive cases with a preceding index patient there was a single case 
of trisomy 21 resulting in an adjusted major anomaly frequency of [(62-29–1)/(568-29-1)] = 
5.9%. The overall excess consanguinity-associated prevalence of congenital anomalies in the 
combined offspring of first cousin and beyond first cousin parents is therefore 5.9%-2.0% = 
3.9%: 6.1% (100x(22-1/275-1-16)% –2%) at first cousin level and 1.9% (100x(11/293-13)%-
2%) beyond first cousin level. By comparison, meta-analyses of multi-national data have 
indicated a 0.5% increase in stillbirths and a 1.25% increase in infant deaths among the 
progeny of first cousin parents2
Where the fetus was diagnosed with a major congenital anomaly there was a high prevalence 
of medical termination of pregnancy in both the consanguineous (50.0%) and non-
. 
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consanguineous pregnancies (60.9%). The high rate of medical terminations of affected 
fetuses conceived by consanguineous couples of Turkish or Eastern Mediterranean origin 
(Tables 3 and 4) appears to indicative of more permissive attitudes towards MTOP within 
some Islamic communities.
As summarized in Table 5, in assessing the influence of parental consanguinity on congenital 
anomalies it is important that prenatal outcomes and early neonatal deaths are fully 
considered,  In the study group, 307/955 (32.2%) fetuses with major anomalies survived the 
first neonatal week, with quite similar survival outcomes in the fetuses of consanguineous 
(35.5%) and non-consanguineous (31.9%) parentage (Table 5). From the perspective of a 
paediatrician, possibly unaware of MTOP, IUD or NND of the child within the first week, the 
frequency of major anomalies in fetuses with consanguineous parentage, including those 
referred following an index case, would have been estimated as 3.9% (22/568). However this 
mode of calculation significantly under-estimates the overall fetal (and neonatal) problems 
that may be associated with consanguineous pregnancies, even in populations where 
consanguineous marriage is quite rare. Appropriate allowance for the influence of 
consanguineous parentage becomes all the more important in multi-ethnic populations where 
a significant proportion of pregnancies are between close biological kin and/or contracted 
within restricted community marriage pools.
24 
With the increasing capacity to maintain fetal life from the second trimester onwards, and to 
rapidly identify rare inherited disorders by methods such as high-level ultrasound
2,3,25,26 
27, whole 
genome sequencing in the prenatal period28  and in neonates29, and diagnostic whole exome 
sequencing30, comprehensive pre- and postnatal procedures need to be devised for adverse 
consanguinity-associated health outcomes.31 At the same time, it is important that the 
information derived be incorporated into genetic counselling programmes that both 
acknowledge and respect the religious and cultural beliefs of couples and their communities, 
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and the perceived social benefits of intra-familial marriage.3,32,33
 
 The present study impinges 
on a potentially very sensitive issue and for this reason the data analysis has been conducted 
with no attempt to draw any form of moral inference from the results. It therefore is 
important that the information derived is not assessed outside a medical context or used as a 
basis for cultural or political discourse. 
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Table 1: Consanguinity, ethnicity and maternal age in mothers of 35,201 fetuses, 1993-2011. 
Information was available on maternal age and ethnicity in all 675 fetuses with 
consanguineous parents but was missing in 190 of the non-consanguineous group. Women in 
consanguineous relationships were significantly younger than in non-consanguineous 
relationships (*t-test, p< 0.0001). 
Ethnic background Consan- 
guineous 
Non-con 
sanguineous 
All Consanguinit
y 
(%) 
Maternal age 
by ethnicity, 
mean + SD, 
range 
European 
 
22 
(3.3%) 
31,042 
(89.9%) 
31,064 
(88.3%) 
0.07% 31.9 + 
15-50 years 
5.2 
Turkish 415 
(61.5%) 
1,994 
(5.8%) 
2,409 
(6.9%) 
17.2% 28.9 + 5.6 
15-47 years 
Eastern Mediterra-
nean / Maghreb 
227 
(33.6%) 
817 
(2.4%) 
1,044 
(3.0%) 
21.8% 29.5 + 6.4 
16-44 years 
African 0 112 
(0.3%) 
112 
(0.3%) 
0% 29.9 + 
18-41 years 
5.2 
Asian 11 
(1.6%) 
561 
(1.6%) 
572 
(1.6%) 
1.9% 31.6 + 
15-47 years 
5.2 
Maternal age 
mean + SD, range 
28.0 + 5.6* 
16-44 
years 
31.7 ± 5.3 
15-50 years 
  31.6 ± 5.4, 
15-50 years 
(Information was available on the ethnic background of all 675 consanguineous fetuses and 
on 99.5% of 34,716 fetuses with non-consanguineous parentage.) 
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Table 2: Frequencies and patterns of inheritance of major congenital disorders in 
consanguineous and non-consanguineous pregnancies. Chi2
Disorders diagnosed 
-tests, †p = 0.23, *p <0.0001 
 
Consan-
guineous % 
Non-
consan-
guineous % 
All cases 
 % 
Total cases 675 100% 34,716 100% 35,391 100% 
Information on fetal 
outcome missing 107 15.9% 3,575 10.3% 3,682 10.4% 
Information on fetal 
outcome available 568 84.1% 31,141 89.7% 31,710 89.6% 
No disorder 504  30,248  30,755  
All congenital 
disorders 62 10.9% 893 2.9% 955 3.0% 
Single gene defects  37 6.51% 40 0.13% 77 0.24% 
Autosomal dominant  0  15 0.05% 15 0.05% 
Autosomal recessive 37 6.51%* 22 0.07% 59 0.19% 
X-linked recessive 0  3 0.01% 3 0.01% 
All chromosomal 
aberrations 4 0.70%† 367 1.18% 371 1.17% 
Numerical 
chromosomal 
aberrations 
2 
 
0.35% 
 
322 
 
1.03% 
 
324 
 
1.02% 
 
    non-gonosomal 1 0.18% 280 0.90% 281 0.89% 
    gonosomal 1 0.18% 42 0.13% 43 0.14% 
Structural 
chromosomal 
aberrations 
1 
 
0.18% 
 
23 
 
0.07% 
 
24 
 
0.08% 
 
Mosaicism 1 0.18% 22 0.07% 23 0.07% 
Molecular genetic 
disorders 0  5 0.02% 5 0.02% 
Anatomically 
complex disorders 
with unclear genetic 
background 
21 
 
3.70% 
 
481 
 
1.54% 
 
502 
 
1.58% 
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Table 3: Overview of 37 cases (group A) showing a probable causal association of the 
diagnosed anomaly with consanguinity. 
No 
 
DOC 
 
Diagnosis 
 
M.o.i. 
 
Fet aff. 
no 
Mode/time 
of detection 
Karyotype 
 
US 
vis Pregnancy outcome 
First cousin cases with a probable causal relation to consanguinity … with a positive history 
1 1C Arthrogryposis   AR/Rep 2 US 32 wks   + NND 6 wks 
2 1C Arthrogryposis   AR/Rep 3 US 29 wks   + NND 3 days 
3 1C Hydrops of unclear origin Rep 2 US 13 wks  + MTOP 19 wks 
4 1C Hydrops of unclear origin* Rep 2 US 28 wks   + IUD 30 wks 
5 
 
1C 
 
Mitochondriopathy 
 
AR/Rep 
 
2 
 
Diag den 
Postnatal   
- Delivery 
NND 11 months 
6 1C Glycogenosis II (Pompe) ** AR/Rep 2 US 21 wks   + Delivery 
7 1C Meckel-Gruber syndrome AR 2 US 22 wks   + MTOP 22 wks 
8 1C Multicystic kidney disease AR/Rep 2 US 21 wks   + NND 1 day 
9 
 
1C 
 
Multiple pterygium syndrome 
 
Rep 
 
2 
 
FBA + US 
31 wks 
46,XX 
 
+ IUD 33 wks 
 
10 1C Multicystic kidney disease AR/Rep 2 US 23 wks   + MTOP 23 wks 
11 1C ß-thalassaemia AR/Rep 2 CVS 13 wks 46,XX - MTOP 17 wks 
12 1C Galactosaemia AR/Rep 2 CVS 12 wks 46,XY - MTOP 15 wks 
13 1C Osteopetrosis AR/Rep 2 CVS 12 wks 46,XY - MTOP 13 wks 
14 1C Fanconi anaemia AR/Rep 2 CVS 13 wks 46,XY - MTOP 15 wks 
15 1C Micro-syndrome AR/Rep  6 CVS 15 wks 46,XY - MTOP 16 wks 
16 1C Mucopolysaccharidosis  VI AR 2+fc.. AC 16 wks 46,XX - MTOP 22 wks 
         
… without a positive history 
17 1C Surfactant-b-deficiency AR 1 Postnatal    - NND 2 wks 
18 1C Citrullinaemia AR 1 Postnatal   - Delivery 
19 1C Meckel-Gruber syndrome AR 1 US 12 wks   + MTOP 13 wks 
20 1C Pierre-Robin-Syndrome AR/Rep 1+f.c.. US 21 wks   + Delivery 
21 
 
1C 
 
Arthrogryposis-renal-
cholestasis-syndrome 
AR 
 
1 
 
Diagnosis 
postnatally 
AC 26 wks: 
46,XX 
 Delivery 
NND 3 months 
Cases beyond first cousins   ... with a positive history 
22 <1C Glycogenosis type II (Pompe) AR/Rep 2 Diag den   - NND 7 months 
23 <1C Glycogenosis type IV AR/Rep 2 Diag den   - NND 14 wks 
24 <1C SMA Werdnig-Hoffmann AR/Rep 2 CVS 12 wks 46,XY - MTOP 17 wks 
25 <1C SMA Werdnig-Hoffmann AR/Rep 3 CVS 12 wks 46,XX - MTOP 14 wks 
26 <1C SMA Werdnig-Hoffmann AR/Rep 3 CVS 20 wks 46,XX - MTOP 23 wks 
27 <1C Adams-Oliver syndrome  Rep 2 US 22 wks   + MTOP 23 wks 
28 <1C Adams-Oliver syndrome  Rep 3 US 13 wks   + MTOP 14 wks 
29 
 
<1C 
 
Unclear syndrome with  
severe mental retardation 
AR/Rep 
 
2 
 
Postnatal 
   
- Delivery 
 
30 <1C Cockayne syndrome AR/Rep 2 CVS 11 wks 46,XX  MTOP 19 wks 
31 <1C Microcephaly Rep 2 US 37 wks   + MTOP 37 wks 
32 <1C COFS AR/Rep 2 US 31 wks    MTOP 31 wks 
33 
 
<1C 
 
Unclear syndrome with cleft  
palate and skeletal dysplasia 
AR/Rep 
 
2 
 
US 16 wks 
   
+ MTOP 16 wks 
 
34 
 
<1C 
 
Unclear skeletal dysplasia 
(OI?) 
AR/Rep 
 
2 
 
US 26 wks 
  
+ Delivery 
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… without a positive history (no preceding affected fetus/child) 
35 <1C Glycogenosis type IV AR/Rep 1 Postnatal   - NND 10 wks 
36 <1C Meckel-Gruber syndrome AR 1 US 12 wks   + MTOP 14 wks 
37 
 
<1C 
 
Microcephaly 
 
Rep 
 1+ fam.c. 
US 21 wks 
   
+ Delivery 
 
 
Cases 4 and 6 were dizygotic twin pregnancies: *in case 4 one of the twins had intrauterine 
demise at 34 weeks; **in case 6 first signs were seen at 21 weeks with diagnosis made 
postnatally; in both cases the co-twins were normal. In the 8 cases of the 4 women printed in 
bold (cases 1 and 2, cases 24 and 25, cases 27 and 28 and cases 35 and 23), the couples had 
several children with an identical diagnosis in different pregnancies. Three of these 4 women 
had a third affected fetus not listed here as Table 3 is based only on cases we examined in our 
centre. Column 5 gives the number the previous affected fetuses of the couple investigated. In 
9 of the 37 cases the anomaly occurred in the family for the first time.  
DOC, degree of consanguinity; 1C, first cousin; <1C, beyond first cousin; mgt molecular 
genetic test; Fet aff. No, fetus affected number; SMA, spinal muscular atrophy: COFS, 
cerebro-oculo-facial syndrome, AR autosomal recessive; Rep, repetitive case; fam.c., familial 
case; CVS, chorionic villous sampling; AC, amniocentesis, US, ultrasound; wks, weeks; Diag 
den, diagnostics declined (pregnant woman did not accept invasive procedure); MTOP, 
medical termination of pregnancy; IUD, intrauterine death; NND, neonatal death. 
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Table 4: Overview of 19 cases with major anomalies (nos. 38-56, group B) showing a 
possible causal association with consanguinity as well as 6 cases with major anomalies (nos. 
57-62, group C) showing an improbable association with consanguinity. Column 4 gives the 
number the previous affected fetuses of the couple investigated 
 
No. 
 
DOC 
 
Diagnosis 
 
Fet 
aff 
no 
Mode/time 
of detection 
 
Karyotype 
 
US 
vis Pregnancy outcome 
 
First cousin cases with a possible causal relation to consanguinity … without a positive history 
38 
 
1C 
 
Hydrops of unclear origin 
 
1 
 
US 23 wks 
CVS+FBA 
46,XX 
 
+ IUD 30 wks 
 
39 
 
1C 
 
Hydrops of unclear origin 
 
1 
 
US 11 wks 
CVS 
46,XX 
 
+ MTOP 14 wks 
 
40 1C Hydrops of unclear origin 1 US 19 wks  + MTOP 22 wks 
41 1C Hydrops of unclear origin 1 US 20 wks  + IUD 28 wks 
42 1C Hydrops of unclear origin 1 US 23 wks  + IUD 23 wks 
43 1C Hydrops of unclear origin 1 US 16 wks  + IUD 16 wks 
44 1C Hydrops, CHD 1 US 19 wks  + MTOP 20 wks 
45 1C Heterotaxy syndrome 1 US 22 wks  + MTOP 22 wks 
46 1C CHD: Taussig-Bing 1 US 22 wks  + MTOP 23 wks 
47 
 
 
1C 
 
 
Complex syndrome: 
Heart, CNS. Prior  
pregnancy hydrocephalus 
1+1 
diffe-
rent 
US 20 wks 
AC 
 
46,XX 
 
 
+ MTOP 23 wks 
 
 
48 
 
1C 
 
Cleft lip and palate 
 
1 
 
US 21 wks 
AC 
46,XY 
 
+ Delivery 
 
Cases beyond first cousin with a possible causal relation to consanguinity   
… without a positive history 
49 
 
<1C 
 
Unclear syndrome with 
hydrothorax 
1 
 
US 14 wks 
CVS 
46,XY 
 
+ Delivery 
 
50 
 
<1C 
 
Unclear syndrome, CHD, 
SUA, stigmata 
1 
 
US 22 wks 
   
+ MTOP 22 wks 
 
51 <1C Complex anomaly of CNS 1 US 24 wks  + Delivery  
52 <1C AV septal defect + CDH 1 US 22 wks  + Delivery 
53 
 
<1C 
 
Complex urogenital 
anomaly 
1 
 
US 21 wks 
  
+ Delivery 
 
54 <1C Heterotaxy syndrome 1 US 22 wks  + Delivery 
55 <1C CDH, history of 5 abortions 1 US 22 wks  + NND day 1 
56 
 
 
<1C 
 
 
Hydrocephalus; prior 
pregnancy: unclear 
syndrome, death 1 year 
1+1 
diffe-
rent 
US 16 wks 
AC 
 
46,XX 
 
 
+ MTOP 17 wks 
 
 
 
First cousin cases with an improbable causal relation to consanguinity  
 … without a positive history 
57 
 
1C 
 
Klinefelter syndrome 
no clinical symptoms 
1 
 
US 17 wks 
AC 
47,XXY 
 
- Delivery 
 
58 
 
1C 
 
Paternal balanced 
translocation 
1 
 
US 13 wks 
CVS 
5 p- 
(cri du chat) 
- MTOP 14 wks 
 
59 1C Bilateral renal agenesis 1 US 21 wks   + MTOP 22 wks 
60 
 
1C 
 
Down syndrome 
enlarged NT 1 
US 13 wks 
CVS 
47,XY 
+21 
+ MTOP 18 wks 
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61 
 
1C 
 
Adactyly dig. 2-4 right 
hand 
1 
 
US 21 wks 
  
+ Delivery 
 
62 
 
 
1C 
 
 
Ebstein's anomaly 
chromosomal anomaly 
 
1 
 
 
US 21wks 
AC+FBA 
 
mosaicism 
46,XY/ 
47,XY,+6 
+ Delivery 
 
 
DOC, degree of consanguinity; Fet aff no , fetus affected number; US vis, visibility by 
ultrasound; wks, weeks; CVS, chorionic villous sampling; US, ultrasound; IUD, intrauterine 
death; MTOP, termination of pregnancy for medical reasons; 1C, first cousin; <1C, beyond 
first cousin; AV septal defect, atrio-ventricular septal defect; CDH, congenital diaphragmatic 
hernia; CHD, congenital heart disease; CNS, central nervous system; SUA, single umbilical 
artery; CVS, chorionic villous sampling; AC, amniocentesis; US, ultrasound; wks, weeks; 
MTOP, medical termination of pregnancy; IUD, intrauterine death; NND, neonatal death; 
NT, nuchal translucency.  
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Table 5: Pregnancy outcomes of fetuses with major anomalies conceived by consanguineous 
and non-consanguineous parents. 
  Consang. Non-consang. All cases 
 
Prenatal 
No. of congenital 
defects 62 893 955 
IUD 
 
6 
(9.7%) 
44 
(4.9%)† 
50 
(5.2%) 
MTOP 
 
31 
(50.0%) 
544 
(60.9%) 
575 
(60.2%) 
Survival to term 
 
25 
(40.3%) 
305 
(34.2%) 
330 
(34.6%) 
Postnatal 
 
 
NND within week 1 
3 
(4.8%) 
20 
(2.2%) 
23 
(2.4%) 
Postneonatal survival 
more than one week 
22* 
(35.5%) 
285 
(31.9%) 
307 
(32.2%) 
*Another six babies (nos.1, 5 ,17 ,22 ,23 ,35) died after the first week but within the first year 
of life because of consanguinity-associated diseases. 
†Chi2
 
-test, p = 0.12 
